Skip to main content
. Author manuscript; available in PMC: 2012 Apr 20.
Published in final edited form as: Curr Pharm Des. 2011 Dec;17(38):4294–4307. doi: 10.2174/138161211798999438

Figure 5.

Figure 5

Biosynthetic approach for the recombinant expression of cyclotides using E. coli expression systems. Cleavage of the leading signal either in vitro [18] or in vivo [19, 20] by appropriate proteases provides the N-terminal Cys residue required for the cyclization. The backbone cyclization of the linear precursor is then mediated by a modified protein splicing unit or intein. Once the linear precursor is cyclized, folding is spontaneous for kalata B1 and MCoTI-I/II cyclotides [1820].